JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TWIO
5051
DELISTED
Trajan Wealth Income Opportunities ETF
TWIO
| $134K | ﹤0.01% |
+15,406
| New | +$138K |
2023 Q1
0 quarters
|
|
5052
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$393M
| $134K | ﹤0.01% |
2,664
+40
| +2% | +$2.02K |
2020 Q4
9 quarters
|
|
5053
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$117M
| $133K | ﹤0.01% |
5,135
-416
| -7% | -$11.2K |
2022 Q4
1 quarter
|
|
5054
Fresenius Medical Care
FMS
$12B
| $133K | ﹤0.01% |
6,293
+2,861
| +83% | +$54.8K |
2013 Q2
39 quarters
|
|
5055
PUT
BridgeBio Pharma
BBIO
$13.1B
| $133K | ﹤0.01% |
+8,000
| New | +$93.3K |
2023 Q1
0 quarters
|
|
5056
Biglari Holdings Class B
BH
$1.16B
| $133K | ﹤0.01% |
787
+190
| +32% | +$31.4K |
2016 Q3
26 quarters
|
|
5057
Blue Ridge Bankshares
BRBS
$363M
| $133K | ﹤0.01% |
13,053
+2,762
| +27% | +$32.8K |
2021 Q2
7 quarters
|
|
5058
First Trust Materials AlphaDEX Fund
FXZ
$356M
| $133K | ﹤0.01% |
+2,043
| New | +$137K |
2023 Q1
0 quarters
|
|
5059
Matthews Emerging Markets Equity Active ETF
MEM
$53.6M
| $133K | ﹤0.01% |
+4,905
| New | +$135K |
2023 Q1
0 quarters
|
|
5060
ProShares UltraShort Bloomberg Crude Oil
SCO
$1.03B
| $132K | ﹤0.01% |
1,306
-741
| -36% | -$76.2K |
2020 Q3
10 quarters
|
|
5061
Bain Capital Specialty
BCSF
$708M
| $131K | ﹤0.01% |
10,965
-28,205
| -72% | -$360K |
2019 Q2
15 quarters
|
|
5062
CALL
Keurig Dr Pepper
KDP
$42.1B
| $131K | ﹤0.01% |
+3,700
| New | +$130K |
2023 Q1
0 quarters
|
|
5063
Sanara MedTech
SMTI
$322M
| $131K | ﹤0.01% |
+3,173
| New | +$134K |
2023 Q1
0 quarters
|
|
5064
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.34B
| $131K | ﹤0.01% |
1,429
+819
| +134% | +$80.6K |
2022 Q2
3 quarters
|
|
5065
Innovator US Equity Buffer ETF February
BFEB
$208M
| $130K | ﹤0.01% |
+4,076
| New | +$127K |
2023 Q1
0 quarters
|
|
|
BRW
5066
Saba Capital Income & Opportunities Fund
BRW
$306M
| $130K | ﹤0.01% |
16,008
| – | – |
2013 Q2
39 quarters
|
|
|
HUYA
5067
Huya Inc
HUYA
$523M
| $130K | ﹤0.01% |
36,065
+12,481
| +53% | +$58.6K |
2018 Q2
19 quarters
|
|
|
KC
5068
Kingsoft Cloud Holdings
KC
$2.81B
| $130K | ﹤0.01% |
+14,597
| New | +$71.5K |
2023 Q1
0 quarters
|
|
5069
PCB Bancorp
PCB
$396M
| $130K | ﹤0.01% |
8,967
-2,921
| -25% | -$50.4K |
2018 Q3
18 quarters
|
|
5070
Purple Innovation
PRPL
$9.37M
| $130K | ﹤0.01% |
1,980
+586
| +42% | +$65.4K |
2018 Q3
18 quarters
|
|
5071
Quantum-Si Incorporated
QSI
$300M
| $130K | ﹤0.01% |
73,897
+18,244
| +33% | +$36K |
2021 Q4
5 quarters
|
|
5072
Trinity Capital Inc
TRIN
$1.66B
| $130K | ﹤0.01% |
+10,177
| New | +$133K |
2023 Q1
0 quarters
|
|
|
MFM
5073
Aberdeen Municipal Income Fund
MFM
$197M
| $130K | ﹤0.01% |
24,349
+23,788
| +4,240% | +$123K |
2022 Q3
2 quarters
|
|
5074
Choiceone Financial
COFS
$494M
| $129K | ﹤0.01% |
5,110
+5,098
| +42,483% | +$141K |
2020 Q2
11 quarters
|
|
5075
Outlook Therapeutics
OTLK
$146M
| $129K | ﹤0.01% |
5,936
+2,571
| +76% | +$57.5K |
2021 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.